Improved survival in limited scleroderma-related pulmonary artery ...
Patients with Scleroderma-related pulmonary artery hypertension (SSc-PAH) have a poor prognosis [1]: sur-vival at the first and second year after diagnosis is esti-mated at around 55 and 22 %, respectively [2]. New studies described improved survival rate up to 80 % at 1 year and 50 % at 3 years related to therapy with new ................
................
To fulfill the demand for quickly locating and searching documents.
It is intelligent file search solution for home and business.
Related download
- scleroderma and survival
- scleroderma and survival gov
- sine scleroderma limited cutaneous and diffused cutaneous systemic
- race scleroderma and survival why is there a difference
- retrospective studies in scleroderma effect of potassium para
- improved survival in limited scleroderma related pulmonary artery
- scleroderma and survival annals of the rheumatic diseases